Leishmaniasis, Cutaneous
Information
- Disease name
- Leishmaniasis, Cutaneous
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00111553 | Completed | Phase 1 | Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis | October 2004 | August 2006 |
| NCT00469495 | Completed | N/A | Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis | February 2007 | November 2008 |
| NCT00480883 | Completed | N/A | Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol | January 2008 | December 2008 |
| NCT03294161 | Completed | Phase 2 | Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis | December 2014 | June 2017 |
| NCT03303898 | Completed | N/A | ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE - | November 10, 2017 | September 1, 2021 |
| NCT03445897 | Completed | Phase 2 | Miltefosine Plus IL Pentamidine for Bolivian CL | January 31, 2016 | February 21, 2018 |
| NCT03969134 | Completed | Phase 2 | A Study to Assess the Safety, Efficacy and Immunogenicity of Leishmania Vaccine ChAd63-KH in PKDL | April 6, 2020 | February 28, 2023 |
| NCT03999970 | Completed | N/A | A Clinical Study to Develop an Uninfected Sand Fly Biting Protocol | October 3, 2019 | January 10, 2020 |
| NCT04841239 | Completed | N/A | Development of Topical Herbal Formulations for Treatment of Cutaneous Leishmaniasis | January 1, 2012 | December 30, 2014 |
| NCT04888130 | Completed | Investigation of an Outbreak Situation of Cutaneous Leishmaniasis Among Military Personnel in French Guiana (CEFELEISH) | December 1, 2020 | May 7, 2021 | |
| NCT01032382 | Completed | Phase 2 | Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK) | January 2010 | July 2011 |
| NCT01083576 | Completed | Phase 2 | Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama | March 2010 | July 2011 |
| NCT02894008 | Completed | Phase 2 | A Study of a New Leishmania Vaccine Candidate ChAd63-KH | November 2016 | December 31, 2019 |
| NCT03096457 | Completed | Phase 2/Phase 3 | Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia | April 15, 2017 | April 1, 2018 |
| NCT01641796 | No longer available | Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis | |||
| NCT00508963 | No longer available | Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis | |||
| NCT05094908 | Recruiting | Phase 1 | Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis | May 3, 2023 | May 2024 |
| NCT05708625 | Recruiting | Phase 3 | Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Leishmaniasis | January 1, 2022 | March 1, 2024 |
| NCT01140191 | Terminated | Phase 2 | Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis | September 2013 | September 2014 |
| NCT03762070 | Unknown status | Evaluation of a Diagnostic Device, CL Detect™ Rapid Test, for the Diagnosis of Cutaneous Leishmaniasis in Peru | October 2, 2018 | April 2019 | |
| NCT04072874 | Withdrawn | Phase 1/Phase 2 | Evaluation of the Safety and Clinical Activity of Curaleish in the Topical Treatment of Cutaneous Leishmaniasis. | January 2021 | July 2022 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D016773